There are 40 resources available
Live Q&A and discussion
Presenter: All Speakers
Session: How to deal with the different challenges in your professional career
Resources:
Webcast
Clinical considerations in treatment decision-making
Presenter: Charlie Gourley
Session: GSK – Molecular profiling in advanced ovarian cancer: What do we know?
Resources:
Webcast
Practical considerations in biomarker testing
Presenter: Xavier Matias-Guiu
Session: GSK – Molecular profiling in advanced ovarian cancer: What do we know?
Resources:
Webcast
Panel discussion
Presenter: Charlie Gourley
Session: GSK – Molecular profiling in advanced ovarian cancer: What do we know?
Resources:
Webcast
Live Q&A and discussion
Presenter: All Speakers
Session: Best of abstracts session
Resources:
Webcast
Long term safety and secondary efficacy end points in the ENGOT-OV16/NOVA phase 3 trial on Niraparib in recurrent ovarian cancer
Presenter: Mansoor Raza Mirza
Session: Best of abstracts session
Resources:
Webcast
Discussion
Presenter: Elise Kohn
Session: Best of abstracts session
Resources:
Slides
Webcast
Live Q&A and discussion
Presenter: All Speakers
Session: Best of abstracts session
Resources:
Webcast
Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: Efficacy and safety from ARIEL4, a randomized phase 3 study
Presenter: Rebecca Kristeleit
Session: Best of abstracts session
Resources:
Slides
Webcast
Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)
Presenter: Kathleen Moore
Session: Best of abstracts session
Resources:
Slides
Webcast